[go: up one dir, main page]

EP1811864B1 - Aliment de transition nutritionnelle liquide pour nourrissons - Google Patents

Aliment de transition nutritionnelle liquide pour nourrissons Download PDF

Info

Publication number
EP1811864B1
EP1811864B1 EP04808713A EP04808713A EP1811864B1 EP 1811864 B1 EP1811864 B1 EP 1811864B1 EP 04808713 A EP04808713 A EP 04808713A EP 04808713 A EP04808713 A EP 04808713A EP 1811864 B1 EP1811864 B1 EP 1811864B1
Authority
EP
European Patent Office
Prior art keywords
precooked
carbohydrate
digestible
composition according
cereal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP04808713A
Other languages
German (de)
English (en)
Other versions
EP1811864A1 (fr
Inventor
Edward Lucian Sliwinski
Jan Michel Veneman
Susan Vreugdenhil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Priority to PL04808713T priority Critical patent/PL1811864T3/pl
Publication of EP1811864A1 publication Critical patent/EP1811864A1/fr
Application granted granted Critical
Publication of EP1811864B1 publication Critical patent/EP1811864B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to the field of liquid, ready-to-eat infant nutrition.
  • a balanced carbohydrate intake is of crucial important for healthy nutrition.
  • Reconstituted powdered products are commonly used as a first step towards solid foods. Infants with the age of 4 to 12 months consume reconstituted powdered cereal preparations, such as NutrixTM and BambixTM(Nutricia B.V., Zoetermeer, The Netherlands). Microbial contamination of the reconstituted liquid product often occurs due to contamination of the hands, the use of dirty towels, contaminated water or spoiled milk. Hence, the use of ready to use liquid formula is preferred. Additionally, reconstituted powdered products may form so-called "hot spots" when being subjected to microwave-heating. These may injure the infant.
  • a further disadvantage of using reconstituted powdered products is that the viscosity tends to increase for a long period, which makes bottle feeding though a teat virtually impossible after some time.
  • ready-to-use liquid products which can (partially) replace the powdered products.
  • Ready-to-use liquid products with a viscosity in the range of 30-300 cps are described in US6099871 .
  • liquid compositions that can (partially) replace the reconstitutable powdered products, and still have an optimal carbohydrate content, are suitable for feeding through a teat (e.g. do not increase to much in viscosity when heated), are physically stable, microbiologically safe and contain sufficient cereal components.
  • indigestible carbohydrate components often tend to sediment on the bottom.
  • cereal components gelatinize when the liquid compositions are sterilized, increasing the viscosity to unacceptable levels, particularly if the composition is to be bottle-fed to an infant through a teat.
  • the present invention provides a liquid nutritional product, which is particularly suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid foods.
  • the present composition is particularly designed to have the infant accustomed to ingredients present in solid foods, particularly cereal based ingredients. Generally, infants in this transition period are between 4 and 18 months old.
  • the present liquid composition has an increased viscosity vis-à-vis liquid infant formula and/or breast milk.
  • the increased viscosity also provides a step towards solid nutrition.
  • the present composition is still sufficiently low in viscosity for bottle-feeding through a teat.
  • the present liquid composition preferably has an increased caloric density compared to human milk and/or liquid infant formula, which is a further step towards solid nutrition.
  • the present composition has an optimal digestible and indigestible carbohydrate content, while having a long shelf life.
  • the digestible carbohydrate fraction of the present composition contains relatively small quantities of monosaccharides (if any). A high content of monosaccharides increases the chances for the development of caries. However if honey is included in the present composition, it may contain fairly high amounts of monosaccharides, as honey does not increase the risk of caries despite the presence of monosaccharides therein.
  • the present composition contains lactose, in order to provide similarity with infant milk formula and/or breast milk. Additional disaccharides in the form of sucrose and/or maltose may be added as sweetener and/or for increasing diversity of ingredients. An increased diversity of ingredients better prepares the infant for consuming solid foods.
  • the composition contains a significant portion of digestible cereal-derived carbohydrate with medium chain length (i.e. a degree of polymerisation between 3 and 250). These are easily digestible cereal-derived carbohydrates, i.e. a first step up towards more complex carbohydrates. As a full-length carbohydrate, precooked flour and/or precooked starch is included in the composition.
  • the full-length carbohydrates have high resemblance with the carbohydrate component in the future solid foods to be combusted. It is however essential that the present starches and/or flour are precooked for a smooth transition, without intestinal discomfort.
  • the present transitional nutrition contains indigestible carbohydrates.
  • Both human milk and many solid foods contain indigestible oligosaccharides.
  • the indigestible oligosaccharide provides significant gastrointestinal and systemic health benefits, e.g. improving moderate constipation and, selectively stimulating the growth of probiotic bacteria.
  • the present composition contains at least a significant amount of indigestible soluble fibers, in order to benefit from the effects.
  • the present composition contains at least two different types of oligosaccharides, e.g.
  • a galactose-based oligosaccharide which has high resemblance with human milk oligosaccharides, and a fruit, vegetable or cereal-based oligosaccharide. This combination makes a particularly good nutrition for the transitional period.
  • the present liquid composition preferably contains insoluble dietary fiber.
  • the amount of insoluble dietary fiber is preferably below 1 gram per liter in order to prevent intestinal discomfort and provide a product with long shelf life.
  • the present composition is user-friendly and healthy for the infants and contains a specific combination of ingredients that provides these characteristics. Excluding one or more of the essential ingredients from the present composition significantly reduces the quality of the composition.
  • the present composition provides a shelf stable and safe product, which provides benefits to the infant.
  • the macronutrient components e.g. the components of the carbohydrate mixture, mutually support each other in the accustomization process of the infant.
  • the present invention provides a liquid composition suitable for feeding to an infant with a viscosity of 20-150 mPas containing:
  • the present invention provides a process for the manufacture of the composition and the use thereof for providing nutrition to an infant of the age between 4 and 18 months.
  • the present invention provides a process for the manufacture of the present composition, comprising admixing lactose; precooked material selected from the group consisting of precooked cereal starch and precooked cereal flour; digestible oligosaccharide with a degree of polymerisation (DP) of 3 - 250; and indigestible oligosaccharide.
  • the present composition provides an optimal blend of digestible di-, oligo-and polysaccharides from different sources, without causing intestinal discomfort for the infant, having good palatability and having a long shelf life.
  • the disaccharides are at least partially provided by lactose; the digestible oligosaccharides have a degree of polymerisation between 3 and 250, and the polysaccharides are provided by precooked cereal flour or precooked cereal starch.
  • a sufficient amount of digestible carbohydrates is essential for infants. Hence, preferably between 40 and 75 % of total calories of the composition (en%) are provided by carbohydrate.
  • the present composition comprises a combination of lactose and digestible cereal-derived carbohydrate.
  • the combination of "digestible animal derived carbohydrate” and digestible plant derived carbohydrate supports the transition period.
  • the weight ratio lactose/digestible cereal derived carbohydrate is between 1 and 10, more preferably between 3 and 6.
  • the present liquid composition preferably contains less than 15 wt.% monosaccharide based on total weight of digestible carbohydrate, preferably below 10 wt.%, most preferably less than 5 wt.%; or, if the composition includes honey, less than 20 wt.% monosaccharide based on total weight of digestible carbohydrate, preferably less than 15 wt.%.
  • the present liquid composition contains honey.
  • the present liquid composition comprises between 40 and 70 wt.% disaccharide based on total weight of digestible carbohydrate, including at least 10 wt.% lactose based on total weight of digestible carbohydrate , preferably at least 40 wt.% lactose.
  • the lactose content does not exceed 70 wt.% based on total weight of digestible carbohydrate, preferably does not exceed 60 wt.%.
  • the present composition may e.g. include sucrose and/or maltose.
  • a high content of lactose is included as disaccharide, for a high similarity with milk and for the prevention of tooth decay.
  • the present composition contains lactose and other digestible carbohydrates, i.e. a mixture of carbohydrates normally present in human breast milk and non-breast milk carbohydrates.
  • both "other" digestible carbohydrates (digestible carbohydrates minus lactose) as well as lactose are present in about equal amounts.
  • the weight ratio [lactose]/[digestible carbohydrate other than lactose] is preferably between 0.25 and 2.5.
  • the present liquid composition preferably comprises between 10 and 30 wt.% digestible, cereal-derived oligosaccharide with a degree of polymerisation (DP) of 3 to 250 based on total digestible saccharides of the present composition. More preferably, the present liquid composition comprises a fraction of digestible oligosaccharides with a DP of 3-10 (hereinafter referred to as "F-DP3-10") and a fraction of digestible oligosaccharides with a DP of 11-250 (hereinafter referred to as "F-DP11-250”), wherein the weight ratio F-DP3-10/F-DP11-250 is preferably between 0.1 and 10, more preferably between 0.25 and 5.
  • F-DP3-10 fraction of digestible oligosaccharides with a DP of 3-10
  • F-DP11-250 fraction of digestible oligosaccharides with a DP of 11-250
  • the present composition comprises between 10 and 40 wt.% precooked material selected from the group consisting of precooked cereal starch and precooked cereal flour, preferably between 20 and 40 wt.% precooked material.
  • precooked starch and precooked cereal flour indicates starch or flour obtained by the process whereby starch or flour, in granular and crystalline structure;
  • precooked cereal flour is used.
  • the precooked cereal flour has a closer resemblance with the ingredients in solid nutrition as it also contains protein.
  • the precooked flour presently used preferably contains between 5 and 15 wt.% protein based on the total dry weight of the precooked flour.
  • the present composition comprises precooked rice flour.
  • the precooked flour or precooked starch may be obtained from baked cookies.
  • the use of precooked starch or precooked flour has the further advantage that the final product has a reduced content of thermo-resistant spores compared to the use of non-precooked flour and/or non-precooked starch.
  • the use of precooked starch and/or precooked flour in the present process for has the advantage that the viscosity differences of the composition before and just after sterilization of the composition are minimal. This in contrast to the situation wherein solely non-precooked flour and/or precooked starch is used.
  • the present composition preferably contains two different precooked cereals (precooked cereal flour or precooked cereal starch) obtained from different plant species, i.e. preferably at least two precooked cereals from a species selected from the group consisting of oat, wheat, corn, rice, rye, barley, spelt, buckwheat, millet, sorghum, triticate and amarant.
  • the precooked flour or precooked starch used in the present invention preferably has a degree of gelatinization of at least 50%, preferably at least 75 %. This gives better water holding capacity (W.H.C), resulting in an improved product (e.g. stability and palatability).
  • WHC of the precooked material used in the present invention is preferably between 2 and 10 gram water/gram dry matter precooked material, more preferably between 2.5 and 5 gram water/gram dry matter precooked material.
  • the WHC can be determined as described by Pinnavaia and Pizzirani (Starch/Starke 50 (1998) nr. 2-3, S. 64-67 ).
  • the present composition comprises an indigestible carbohydrate fraction containing soluble indigestible oligosaccharide with a degree of polymerisation (DP) between 2 and 100, preferably a DP between 2 and 50.
  • Indigestible carbohydrates are also referred to dietary fiber.
  • Preferably at least 50 wt.% of the total indigestible carbohydrate fraction is soluble indigestible oligosaccharide, more preferably at least 75 wt.%.
  • the soluble oligosaccharides have the advantage that they provide both health benefits to the infant, and give good product characteristics, e.g. the soluble fibers do not precipitate and hardly react with other ingredients of the present composition.
  • the present composition preferably contains 0.5 to 12 grams of the indigestible soluble oligosaccharides per 100 gram dry weight of the liquid composition, preferably between 0.5 and 8 grams, more preferably between 1.0 and 7.5 grams.
  • indigestible oligosaccharides and "indigestible carbohydrate” as used in the present invention refers to oligosaccharides/carbohydrate which are not or only partially digested in the intestine by the action of acids or digestive enzymes present in the human upper digestive tract (small intestine and stomach) but which are fermented by the human intestinal flora.
  • soluble when having reference to a polysaccharide, fibre or oligosaccharide, means that the substance is at least 50% soluble according to the method described by L. Prosky et al., J. Assoc. Off. Anal. Chem. 71, 1017-1023 (1988) .
  • Human milk also contains galactose-based oligosaccharides.
  • the present composition preferably includes at least a galactose-based indigestible oligosaccharide which is at least highly similar to the galactose-based oligosaccharides as present in human milk.
  • galactose-based indigestible oligosaccharide refers to an indigestible saccharide, wherein at least 30 % of the saccharide units are galactose units, preferably at least 50 %, more preferably at least 60%.
  • the saccharides of the galactose-based oligosaccharide are ⁇ -linked, as is the case in human milk.
  • the galactose-based indigestible oligosaccharide is selected from the group consisting of transgalactooligosaccharide, galactooligosaccharide, lacto-N-tetraose (LNT) and lacto-N-neotetraose (neo-LNT).
  • the present method comprises the administration of transgalactooligosaccharide ([galactose] n -glucose; wherein n is an integer between 1 and 60, i.e. 2, 3, 4, 5, 6, .
  • Transgalactooligosaccharides are for example sold under the trademark VivinalTM (Borculo Domo Ingredients, Netherlands).
  • VivinalTM Bovine TungstenTM
  • the saccharides of the transgalactooligosaccharides are ⁇ -linked.
  • the present composition preferably comprises 0.1 to 12 grams of the galactose-based oligosaccharides per 100 gram dry weight of the liquid composition, preferably between 0.5 and 8 grams, more preferably between 1.0 and 7.5 grams.
  • the present composition contains indigestible soluble oligosaccharides which have a high resemblance with fruit, cereal and/or vegetable soluble indigestible oligosaccharides. These oligosaccharides are hereinafter referred to "non-galactose based oligosaccharides".
  • the present composition contains an oligosaccharides selected from the group consisting of indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligosaccharides, isomalto-oligosaccharide and fructopolysaccharide.
  • fructopolysaccharide widely occurs in solid foods (e.g. onion, banana, artichokes)
  • the present composition preferably comprises fructopolysaccharide.
  • fructopolysaccharide refers to a polysaccharide carbohydrate comprising a chain of at least 3 ⁇ -linked fructose units, with a DP between 3 and 300, preferably between 20 and 150.
  • inulin is used.
  • Inulin is available under the tradename "Raftilin HP®", (Orafti).
  • the term “inulin” is used herein to refer to glucose-terminated fructose chains with at least 90% fructose units having a DP between 10 and 300.
  • Inulin can be described as GF n' wherein G represents a glucosyl unit, F represents a fructosyl unit and n is the number of fructosyl units linked to each other, n being 9 or more. A small part of the inulin molecules, however, may have no terminal glucose unit, due to hydrolysis during processing.
  • the average DP of the fructopolysaccharide is preferably at least 15, more preferably at least 20 or more, up to 300.
  • the fructose units are linked with a ⁇ (2 ⁇ 1) linkage.
  • Indigestible polydextrins refer to digestion-resistant (malto)dextrins or digestion-resistant polydextrose which have a DP of 10 to 50, preferably between 10 and 20.
  • Indigestible polydextins are at least 75% indigestible, preferably at least 90 % indigestible These indigestible polydextrins are preferably produced by a combination of hydrolysis and transglucosidation reactions.
  • the indigestible polydextrins comprise ⁇ (1 ⁇ 4), ⁇ (1 ⁇ 6) glucosidic bonds and 1 ⁇ 2 and 1 ⁇ 3 linkages
  • Indigestible polydextrins are for example available under the tradename "Fibersol 2®" from Matsutami Inductries or Litesse® from Danisco.
  • the present liquid nutrition comprises both the galactose-based oligosaccharides (for the human milk resemblance) and the non-galactose based oligosaccharide (for the preparation of solid foods).
  • the present composition preferably has a high content of galactose based oligosaccharides.
  • the weight ratio galactose based oligosaccharides: non-galactose based oligosaccharides is 100:1 to 1:2, preferably 50:1 to 1:1.
  • the composition contains, per 100 ml liquid product, between 0.1 and 0.7 gram transgalactooligosaccharides; and between 0.01 and 0.3 gram inulin.
  • the present composition contains insoluble, indigestible fibers, preferably in an amount below 1 gram per 100 ml, preferably between 0.1 and 0.5 gram per 100 ml.
  • the present transition nutrition preferably contains protein, even more preferably a combination of animal protein and cereal protein, wherein the cereal protein comprises preferably at least one protein selected from the group consisting of rice protein, com protein, wheat protein and oat protein.
  • the present liquid composition preferably contains between 1.5 and 3 g protein per 100 ml, preferably between 2 and 3 grams.
  • the weight ratio animal milk protein: cereal protein is preferably 1:1 to 10:1.
  • the present composition is particularly suitable for use as a nutritional composition for providing nutrition to an infant with the age between 4 and 18 months.
  • the present composition is bottle fed (orally through a teat) to the infant.
  • the present composition preferably contains protein, carbohydrate and fat, more preferably between 7 and 12.5 en% protein, between 40 and 75 en% carbohydrate and between 25 and 40 en% fat.
  • the present composition is preferably provided as a packaged product containing between 150 and 550 ml of the present liquid composition in ready-to-use form.
  • ready-to-use form means that the composition does not require admixture of components such as water, milk or sugar prior to administration to the infant.
  • the packaged products preferably contain one or two serving sizes, i.e. contain between 150 and 550 ml of the present liquid product per package. Most preferably the present liquid composition is packaged per serving of between 175 and 275 ml.
  • the liquid composition of the packaged product according to the present invention is transferred to bottle suitable for carrying a teat. Said liquid composition is preferably heated in the bottle to a temperature between 30 and 38°C, followed by connecting the teat to the bottle and feeding the liquid composition to the infant through a teat.
  • the viscosity of the present composition preferably remains relatively constant during this time interval.
  • the viscosity of the present composition does not exceed 150% of the viscosity of the ready-to-use composition at room temperature before heating, during the 30 minute interval starting when the present liquid composition is heated to 37°C.
  • the present composition preferably contains long chain polyunsaturated fatty acids, to prove a further acquaintance to ingredients in solid food, and more importantly, provide the infant with appropriate components for a proper neurological development.
  • the present composition contain between 0.05 and 5 wt.% docosahexaenoic acid (DHA, n3) based on the total weight of lipids and/or between 0.05 and 5 wt.% arachidonic acid (AA, n3) based on the total weight of the lipids.
  • the present composition preferably comprises at least 0.1 wt.%, preferably at least 0.25 wt, more preferably at least 0.5 wt.%, even more preferably at least 0.75 wt.% long chain polyunsaturated fatty acid (LC-PLTFA) with 20 and 22 carbon atoms based on the total fat content.
  • LC-PLTFA long chain polyunsaturated fatty acid
  • the present composition comprises AA, EPA (eicosapentaenoic acid, n3) and DHA, wherein the weight ratio AA/DHA preferably is above 0.25, preferably above 0.5, even more preferably above 1.
  • the ratio is preferably below 25.
  • the weight ratio AA/EPA is preferably between 1 and 100, more preferably between 5 and 20.
  • Example 1 Cereal milk for infants
  • Cereal part Hydrolyzed rice flour (33kg); Pre-cooked rice flour (15 kg); Pre-cooked corn flour (15 kg); Pre-cooked waxy corn starch (10 kg); Sucrose (52 kg); Glucidex® 19 IT (2.4 kg; Roquette, Lestrem, France)
  • Example 2 Cereal milk for infants with honey
  • Example 3 Milk and Cereal with honey

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Seasonings (AREA)

Claims (10)

  1. Composition liquide appropriée pour l'alimentation d'un nouveau-né ayant une viscosité de 20 à 150 mPas contenant :
    a. une fraction de glucide facile à digérer contenant :
    - moins de 20 % en poids de monosaccharide sur la base du poids total de glucide facile à digérer si la composition comprend du miel ou moins de 15 % en poids de monosaccharide sur la base du poids total de glucide facile à digérer ;
    - entre 20 et 70 % en poids de disaccharide sur la base du poids total de glucide facile à digérer, dans laquelle au moins 10 % en poids sur la base du poids total de glucide facile à digérer est du lactose ;
    - entre 10 et 30 % en poids d'oligosaccharide facile à digérer ayant un degré de polymérisation (DP) de 3 à 250 ;
    - entre 10 et 40 % en poids de matière précuite choisie dans le groupe constitué de l'amidon de céréales précuites et de la farine de céréales précuites, sur la base du poids total de glucide facile à digérer ;
    - un rapport en poids lactose/glucide dérivé de céréales facile à digérer compris entre 0,25 et 2,5 ; et
    b. une fraction de glucide non facile à digérer contenant au moins 50 % en poids d'oligosaccharide non facile à digérer soluble ayant un degré de polymérisation (DP) compris entre 2 et 100.
  2. Composition selon l'une quelconque des revendications précédentes, dans laquelle la protéine constitue de 7 à 12,5 %, le glucide de 40 à 75 % et la graisse de 25 à 40 % de la teneur calorique totale.
  3. Composition selon l'une quelconque des revendications précédentes, dans laquelle le rapport en poids protéine animale : protéine de céréales est de 1 : 1 à 10:1.
  4. Composition selon l'une quelconque des revendications précédentes, dans laquelle la composition contient de la farine de céréales précuites.
  5. Composition selon l'une quelconque des revendications précédentes, comprenant en outre un glucide non facile à digérer insoluble.
  6. Composition selon l'une quelconque des revendications précédentes, comprenant un oligosaccharide à base de galactose et un fructopolysaccharide.
  7. Composition selon l'une quelconque des revendications précédentes, dans laquelle la matière précuite a une capacité de rétention d'eau comprise entre 2 et 10 grammes d'eau/gramme de matière sèche de la matière précuite.
  8. Produit emballé contenant de 150 à 550 mL de la composition liquide selon l'une quelconque des revendications 1 à 7 sous une forme prête à l'emploi.
  9. Utilisation d'une composition selon l'une quelconque des revendications 1 à 8 pour la fabrication d'une composition nutritionnelle destinée à la nutrition d'un nouveau-né âgé de 4 à 18 mois.
  10. Procédé de fabrication d'une composition selon l'une quelconque des revendications 1 à 7, comprenant le mélange de lactose ; de matière précuite choisie dans le groupe constitué de l'amidon de céréales précuites et de la farine de céréales précuites ; d'oligosaccharide facile à digérer ayant un degré de polymérisation (DP) de 3 à 250 ; et d'oligosaccharide non facile à digérer.
EP04808713A 2004-11-12 2004-11-12 Aliment de transition nutritionnelle liquide pour nourrissons Expired - Lifetime EP1811864B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL04808713T PL1811864T3 (pl) 2004-11-12 2004-11-12 Płynny pokarm dla niemowląt w okresie przejściowym

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2004/000797 WO2006052125A1 (fr) 2004-11-12 2004-11-12 Aliment de transition nutritionnelle liquide pour nourrissons

Publications (2)

Publication Number Publication Date
EP1811864A1 EP1811864A1 (fr) 2007-08-01
EP1811864B1 true EP1811864B1 (fr) 2008-05-14

Family

ID=34959403

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04808713A Expired - Lifetime EP1811864B1 (fr) 2004-11-12 2004-11-12 Aliment de transition nutritionnelle liquide pour nourrissons

Country Status (11)

Country Link
US (3) US20080292774A1 (fr)
EP (1) EP1811864B1 (fr)
CN (1) CN101098633B (fr)
AT (1) ATE394940T1 (fr)
AU (1) AU2004324720B2 (fr)
CA (1) CA2587468C (fr)
DE (1) DE602004013848D1 (fr)
ES (1) ES2305894T3 (fr)
PL (1) PL1811864T3 (fr)
PT (1) PT1811864E (fr)
WO (1) WO2006052125A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486668B2 (en) 2009-02-24 2013-07-16 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8492124B2 (en) 2009-02-24 2013-07-23 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9226933B2 (en) 2004-07-22 2016-01-05 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010068086A1 (fr) * 2008-12-11 2010-06-17 N.V. Nutricia Composition nutritionnelle à globules de lipides de grande taille
CA2761573A1 (fr) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm 1-2618) et troubles immunitaires
WO2014035470A1 (fr) * 2012-08-31 2014-03-06 Tegel Daniel Semoule et compositions de farine à teneur élevée en protéines et procédés associés
EP3082467A1 (fr) * 2013-12-19 2016-10-26 Abbott Laboratories Composition nutritionnelle translucide présentant un degré d'acidité élevé, une faible viscosité et une densité calorique élevée
EP3193638A1 (fr) * 2014-09-01 2017-07-26 N.V. Nutricia Produits alimentaires stadifiés pour nourrissons et enfants
US10993970B2 (en) 2016-12-19 2021-05-04 Hany Z. ALY Medical-grade honey for growth enhancement of infants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317156A (en) * 1969-06-05 1973-05-16 Boots Co Ltd Babies napkins
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US6194009B1 (en) * 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
US6077558A (en) * 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
CA2432884C (fr) * 2000-12-27 2008-01-22 N.V. Nutricia Composition nutritive benefiques pour la sante contenant des oligosaccharides

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9226933B2 (en) 2004-07-22 2016-01-05 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US8486668B2 (en) 2009-02-24 2013-07-16 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8492124B2 (en) 2009-02-24 2013-07-23 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9579340B2 (en) 2009-02-24 2017-02-28 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9592248B2 (en) 2009-02-24 2017-03-14 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9775860B2 (en) 2009-02-24 2017-10-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use

Also Published As

Publication number Publication date
CA2587468A1 (fr) 2006-05-18
AU2004324720B2 (en) 2011-10-27
WO2006052125A1 (fr) 2006-05-18
CN101098633A (zh) 2008-01-02
AU2004324720A1 (en) 2006-05-18
ATE394940T1 (de) 2008-05-15
US20140199431A1 (en) 2014-07-17
PL1811864T3 (pl) 2008-10-31
DE602004013848D1 (de) 2008-06-26
CN101098633B (zh) 2011-07-27
EP1811864A1 (fr) 2007-08-01
ES2305894T3 (es) 2008-11-01
US20120201922A1 (en) 2012-08-09
PT1811864E (pt) 2008-10-28
CA2587468C (fr) 2012-08-28
US20080292774A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
US10440982B2 (en) Cereal-based infant nutrition with fibre
US20120201922A1 (en) Liquid transition nutrition for infants
RU2471375C2 (ru) Педиатрическая смесь пищевых волокон
EP1957084B1 (fr) Préparation contenant des oligosaccharides pour le traitement prophylactique/thérapeutique de la fiebre et des crises hyperpyrétiques
CN104135872A (zh) 妊娠期间特定碳水化合物系统用于影响后代的用途
CN105007756A (zh) 特定碳水化合物系统在怀孕期间用于防止孕妇的脂肪蓄积的用途
Kuthiala et al. Benefits of functional oligosaccharides (FOS) in treating functional bowel disorders (FBD) and low caloric substitutes for diabetics
RU2375920C2 (ru) Жидкое переходное питание для младенцев
EP2614724A1 (fr) Utilisation de systèmes de carbohydrates spécifiques pendant la grossesse pour réduire les effets nocifs sur la santé plus tard dans la progéniture
Anadón et al. Prebiotics: safety and toxicity considerations
CN113905742A (zh) 保持健康体重或减轻体重的非治疗性方法
HK1187498A (en) Use of specific carbohydrate systems during pregnancy for reducing adverse health effects later in life in offspring

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

DAX Request for extension of the european patent (deleted)
GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REF Corresponds to:

Ref document number: 602004013848

Country of ref document: DE

Date of ref document: 20080626

Kind code of ref document: P

REG Reference to a national code

Ref country code: RO

Ref legal event code: EPE

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: BUGNION S.A.

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20080401977

Country of ref document: GR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080514

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20081014

REG Reference to a national code

Ref country code: PL

Ref legal event code: T3

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2305894

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E003883

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080914

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080814

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080514

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080514

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20090217

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080814

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080514

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080514

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081112

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602004013848

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A23L0001290000

Ipc: A23L0033000000

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20161125

Year of fee payment: 13

Ref country code: NL

Payment date: 20161111

Year of fee payment: 13

Ref country code: CZ

Payment date: 20161111

Year of fee payment: 13

Ref country code: IE

Payment date: 20161128

Year of fee payment: 13

Ref country code: GB

Payment date: 20161130

Year of fee payment: 13

Ref country code: HU

Payment date: 20161123

Year of fee payment: 13

Ref country code: FI

Payment date: 20161125

Year of fee payment: 13

Ref country code: FR

Payment date: 20161128

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20161124

Year of fee payment: 13

Ref country code: BE

Payment date: 20161125

Year of fee payment: 13

Ref country code: PT

Payment date: 20161102

Year of fee payment: 13

Ref country code: ES

Payment date: 20161223

Year of fee payment: 13

Ref country code: PL

Payment date: 20161102

Year of fee payment: 13

Ref country code: IT

Payment date: 20161123

Year of fee payment: 13

Ref country code: RO

Payment date: 20161024

Year of fee payment: 13

Ref country code: GR

Payment date: 20161130

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20161102

Year of fee payment: 13

Ref country code: DE

Payment date: 20170131

Year of fee payment: 13

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602004013848

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20171201

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 394940

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171112

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20171112

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180514

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171130

Ref country code: FI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: HU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171113

Ref country code: RO

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180604

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180731

Ref country code: BE

Ref legal event code: MM

Effective date: 20171130

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180602

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171201

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171112